Case report: Mild phenotype of a patient with vascular Ehlers–Danlos syndrome and COL3A1 duplication mutation without alteration in the [Gly-X-Y] repeat sequence
Authors:
Open Access
- 18 November 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 1017446
Abstract
Background: Vascular-type Ehlers–Danlos syndrome (vEDS) is an autosomal dominant inherited disorder caused by a deficit in collagen III as a result of heterogeneous mutations in the α1 type III collagen gene (COL3A1). Patients with vEDS often experience the first major complications in their early 20s and >80% have at least one complication by their 40s, reducing their average life expectancy to 48 years. Most commonly, vEDS variants are heterozygous missense substitutions of a base-pair encoding a glycine (Gly) residue of the [Gly-X-Y] repeat of the COL3A1 protein. When a peptide chain derived from a mutant allele is present in the procollagen triple helical structure, the helical structure cannot be maintained. Therefore, typically, the mutated collagen peptide induces a dominant negative effect on procollagen production. We reported the case of a patient with vEDS and a unique novel duplication mutation without alteration in the [Gly-X-Y] triplet repeat sequence.Case presentation: A 58-year-old man developed a sudden disorder of consciousness and abdominal pain and was consequently taken to a nearby hospital, where an intra-abdominal aneurysm was found, in addition to mild small joint hypermobility and acrogeria. There has been no history of spontaneous pneumothorax, dislocation, or subcutaneous hematoma. The analysis of genomic DNA from a blood sample identified a likely pathogenic in-frame duplication mutation in the COL3A1 gene coding region. Interestingly, this mutation is not expected to alter the [Gly-X-Y] triplet repeat sequence. We verified the mutation’s pathogenicity by performing an analysis of synthetic procollagen from cultured skin fibroblasts, electron microscopy, and mRNA expression analysis of unfolded protein response sensors for endoplasmic reticulum (ER) stress.Conclusion: Although the clinical findings of the case were mild, when compared to typical vEDS, decreased α1 collagen III levels and morphological abnormalities of the collagenous bundles were observed in the patient samples when compared with the normal control samples. Our evidence supports the conclusion that this variant is pathogenic. However, unlike the common vEDS, ER stress was not observed, and the mild phenotype presentation was suggested to be due to the unique mutation, allowing the triple helical structure to be maintained to a certain extent.Keywords
This publication has 17 references indexed in Scilit:
- The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndromeEuropean Journal of Human Genetics, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Survival is affected by mutation type and molecular mechanism in vascular Ehlers–Danlos syndrome (EDS type IV)Genetics in Medicine, 2014
- Allele‐specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers‐Danlos syndrome in human fibroblastsThe FASEB Journal, 2011
- Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndromeBritish Journal of Dermatology, 2010
- ATF6α Optimizes Long-Term Endoplasmic Reticulum Function to Protect Cells from Chronic StressDevelopmental Cell, 2007
- ER stress and the unfolded protein responseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- The Ehlers-Danlos syndrome: on beyond collagensJournal of Clinical Investigation, 2001
- Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular TypeNew England Journal of Medicine, 2000
- Mutations in the COL3A1 Gene Result in the Ehlers–Danlos Syndrome Type IV and Alterations in the Size and Distribution of the Major Collagen Fibrils of the DermisJournal of Investigative Dermatology, 1997